Global civil society groups call on the UN Secretary-General to ensure the independence, credibility and representativeness of the UN review's expert panel, and to champion meaningful, rights-affirming reform.
Decision-makers must invest in ending punitive drug policies and responses in favour of rights-based approaches that prioritise harm reduction and community leadership.
PsychedeliCare calls on the European Commission to foster equitable, timely, affordable, safe, and legal access to innovative psychedelic-assisted therapies.
HRI underscores how debates on drug policy, the death penalty, and HIV, supported by civil society advocacy, stressed the centrality of human rights, harm reduction, and proportionality.
French bill proposes draconian expansion of surveillance powers in the name of drug control, despite lack of evidence for efficacy and substantial risks for privacy, digital security, and civil liberties.
In response to emerging challenges, this UNAIDS strategy will propose bold, multisectoral, evidence-based targets to end AIDS as a public health threat.
Amid US funding freezes, the future of clinics and healthcare services around the world is unclear, putting decades of progress in the global fight against HIV at risk.
